1.
Am J Cardiol
; 217: 25-28, 2024 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38432337
RESUMO
What is the efficacy and safety of transcatheter tricuspid valve-in-valve implantation for patients with inoperable tricuspid surgical prosthesis dysfunction? Thirty-day mortality after greatly effective transcatheter treatment is 2 times less than the estimated surgical risk.